Literature DB >> 25572010

Ablation of atrial fibrillation.

Matthew Wright1, Sanjiv M Narayan2.   

Abstract

Ablation is increasingly used to treat AF, since recent trials of pharmacological therapy for AF have been disappointing. Ablation has been shown to improve maintenance of sinus rhythm compared to pharmacological therapy in many multicenter trials, although success rates remain suboptimal. This review will discuss several trends in the field of catheter ablation, including studies to advance our understanding of AF mechanisms in different patient populations, innovations in detecting and classifying AF, use of this information to improve strategies for ablation, technical innovations that have improved the ease and safety of ablation, and novel approaches to surgical therapy and imaging. These trends are likely to further improve results from AF ablation in coming years as it becomes an increasingly important therapeutic option for many patients.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25572010      PMCID: PMC4764083          DOI: 10.1016/j.tcm.2014.11.009

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  102 in total

1.  Atrial conduction slows immediately before the onset of human atrial fibrillation: a bi-atrial contact mapping study of transitions to atrial fibrillation.

Authors:  Gautam G Lalani; Amir Schricker; Michael Gibson; Armand Rostamian; David E Krummen; Sanjiv M Narayan
Journal:  J Am Coll Cardiol       Date:  2012-02-07       Impact factor: 24.094

2.  Circumferential pulmonary-vein ablation for chronic atrial fibrillation.

Authors:  Hakan Oral; Carlo Pappone; Aman Chugh; Eric Good; Frank Bogun; Frank Pelosi; Eric R Bates; Michael H Lehmann; Gabriele Vicedomini; Giuseppe Augello; Eustachio Agricola; Simone Sala; Vincenzo Santinelli; Fred Morady
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

Review 3.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

4.  Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses.

Authors:  Sanjeev Saksena; April Slee; Albert L Waldo; Nick Freemantle; Mathew Reynolds; Yves Rosenberg; Snehal Rathod; Shannon Grant; Elizabeth Thomas; D George Wyse
Journal:  J Am Coll Cardiol       Date:  2011-11-01       Impact factor: 24.094

5.  Repolarization alternans reveals vulnerability to human atrial fibrillation.

Authors:  Sanjiv M Narayan; Michael R Franz; Paul Clopton; Etienne J Pruvot; David E Krummen
Journal:  Circulation       Date:  2011-06-06       Impact factor: 29.690

6.  A comprehensive evaluation of rhythm monitoring strategies for the detection of atrial fibrillation recurrence: insights from 647 continuously monitored patients and implications for monitoring after therapeutic interventions.

Authors:  Efstratios I Charitos; Ulrich Stierle; Paul D Ziegler; Malte Baldewig; Derek R Robinson; Hans-Hinrich Sievers; Thorsten Hanke
Journal:  Circulation       Date:  2012-07-23       Impact factor: 29.690

7.  Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation.

Authors:  Sanghamitra Mohanty; Prasant Mohanty; Luigi Di Biase; Rong Bai; Agnes Pump; Pasquale Santangeli; David Burkhardt; Joseph G Gallinghouse; Rodney Horton; Javier E Sanchez; Shane Bailey; Jason Zagrodzky; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2012-04-03       Impact factor: 24.094

8.  Catheter ablation of atrial fibrillation without fluoroscopy using intracardiac echocardiography and electroanatomic mapping.

Authors:  John D Ferguson; Adam Helms; J Michael Mangrum; Srijoy Mahapatra; Pamela Mason; Ken Bilchick; George McDaniel; David Wiggins; John P DiMarco
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-12

9.  Noninvasive panoramic mapping of human atrial fibrillation mechanisms: a feasibility report.

Authors:  Michel Haissaguerre; Meleze Hocini; Ashok J Shah; Nicolas Derval; Frederic Sacher; Pierre Jais; Remi Dubois
Journal:  J Cardiovasc Electrophysiol       Date:  2013-02-01

10.  Reduced fluoroscopy during atrial fibrillation ablation: benefits of robotic guided navigation.

Authors:  Daniel Steven; Helge Servatius; Thomas Rostock; Boris Hoffmann; Imke Drewitz; Kai Müllerleile; Arian Sultan; Muhammet Ali Aydin; Thomas Meinertz; Stephan Willems
Journal:  J Cardiovasc Electrophysiol       Date:  2009-09-28
View more
  3 in total

Review 1.  Making better scar: Emerging approaches for modifying mechanical and electrical properties following infarction and ablation.

Authors:  Jeffrey W Holmes; Zachary Laksman; Lior Gepstein
Journal:  Prog Biophys Mol Biol       Date:  2015-11-23       Impact factor: 3.667

Review 2.  Atrial fibrillation driver mechanisms: Insight from the isolated human heart.

Authors:  Thomas A Csepe; Brian J Hansen; Vadim V Fedorov
Journal:  Trends Cardiovasc Med       Date:  2016-05-24       Impact factor: 6.677

Review 3.  Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease.

Authors:  Robert G Gourdie; Stefanie Dimmeler; Peter Kohl
Journal:  Nat Rev Drug Discov       Date:  2016-06-24       Impact factor: 84.694

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.